Companies: 10,795·Total market cap: $144.5T

TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.

TLSINASDAQHealthcare● Active

$3.21

+$0.04(+1.26%)

Market Cap$121691610

P/E Ratio—

52W High$7.95

52W Low$2.2

Avg Volume367K

Open$3.13

Beta0.49

股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

TriSalus Life Sciences, Inc.（TLSI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TLSI · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.41Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$44.9MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding49.2MShares outstanding history

Next EarningsAug 11, 2026Est.Earnings history

探索 TriSalus Life Sciences, Inc. 数据

分析师预测$8 · Buy

股息不分红

营收$45.2M+53.41%

盈利EPS $-1.84-47.20%

财务快照

FY 2025Revenue$45.2M▲ +53.41% YoY

202320242025

FY 2025Net Income-$39.2M▼ 18.04% YoY

202320242025

FY 2025EPS$-1.84▼ 47.20% YoY

202320242025

TTM:Revenue: $44.9MNet Income: -$27.3MEPS: $-1.41View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$8.00Low

$3.21Current

$8.00Avg Target上涨空间 149.22%

$8.00High

合计: 3 · 买入占比: 100.0%

根据过去 3 个月内 3 位华尔街分析师，TLSI 共识评级为 Buy，12 个月平均目标价 $8.00 （较现价 $3.21 上涨空间 149.22%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

TriSalus Life Sciences, Inc.

$3.21+1.26%$121.7M #2

Armata Pharmaceuticals, Inc.

$7.57+0.93%$277.9M #3

Anteris Technologies Global Corp.

$9.34-3.11%$343.6M #4

Perspective Therapeutics, Inc.

$2.93-3.30%$226.3M #5

$5.60+0.00%$67.8M #6

$1.15+0.88%$123.2M

股票表现

1D+1.26%

1W-3.89%

1M-27.54%

3M-28.19%

YTD-54.01%

1Y-42.58%

5Y-67.48%

关于 TriSalus Life Sciences, Inc.

CEOMary T. Szela

IPO DateFeb 8, 2021

Employees110

CountryUS

Websitetrisaluslifesci.com

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver an…

Medical - Devices HealthcareNASDAQUS

关于股票概览与关键数据

TriSalus Life Sciences, Inc.（TLSI）是 Medical - Devices 行业的 Healthcare 类公司，于 Feb 8, 2021 在 NASDAQ 上市。截至最近交易日，TLSI 股价为 $3.21，市值约为 $121.7M。过去12个月累计回报 -42.58%，年初至今回报 -54.01%。

根据 3 位华尔街分析师，TriSalus Life Sciences, Inc. 股票共识评级为Buy，12个月平均目标价为 $8.00。2025 财年 TriSalus Life Sciences, Inc. 营收 $45.2M，净利润 -$39.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，TriSalus Life Sciences, Inc.（TLSI）股价为 $3.21，在 NASDAQ 上市，52周区间为 $2.20 – $7.95。

TLSI 最新股价TLSI quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议